Nucleos(t)ide analogues for the treatment of chronic hepatitis B: a systematic review with network meta-analysis

Author:

Geng JinSong1ORCID,Bao HaiNi1ORCID,Chen YaLan1ORCID,Shi LiLi1,Geng Jing2,Wang Qing3,Yu Hao4ORCID

Affiliation:

1. Evidence-based Medicine Center, Medical School of Nantong University, Jiangsu, China

2. Department of Gastroenterology, Lianyungang No 1 People’s Hospital, Jiangsu, China

3. Department of Infectious Disease, Ningxiang People’s Hospital, Hunan, China

4. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA, USA

Funder

the National Natural Science Foundation of China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Reference80 articles.

1. World Health Organization. Global Hepatitis Report 2017. World Health Organization; 2017.

2. World Health Organization. Global Health Sector Strategy on Viral Hepatitis 2016–2021: Towards Ending Viral Hepatitis. World Health Organization; 2016.

3. Serum Level of Antibodies Against Hepatitis B Core Protein Is Associated With Clinical Relapse After Discontinuation of Nucleos(t)ide Analogue Therapy

4. Efficacy and safety of long term entecavir in chronic hepatitis B treatment naïve patients in clinical practice

5. Effects of entecavir and lamivudine for hepatitis B decompensated cirrhosis: Meta-analysis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3